Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo N Makris

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Kidney International|January 25, 2025
Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Kidney International|November 21, 2025
Corrigendum to "Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial." Kidney International 2025;107:740-750Mahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2026
Safety and Efficacy of the WRAPSODY® Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Non-Randomized Arm of the WAVE TrialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2026
One-year Clinical Outcomes from the Randomized-Controlled Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) TrialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Kidney International|August 22, 2025
The authors replyMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Kidney International|January 25, 2025
Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Kidney International|November 21, 2025
Corrigendum to "Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial." Kidney International 2025;107:740-750Mahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2026
Safety and Efficacy of the WRAPSODY® Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Non-Randomized Arm of the WAVE TrialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2026
One-year Clinical Outcomes from the Randomized-Controlled Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) TrialMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Kidney International|August 22, 2025
The authors replyMahmood K Razavi, Saravanan Balamuthusamy, Angelo N Makris, et al.
Pageof 1